HR23B, a biomarker for HDAC inhibitors
<p>As our understanding of cancer biology increases and novel therapies are developed, an increasing number of predictive biomarkers are becoming clinically available. Aberrant acetylation has been strongly linked to tumourigenesis and the modulation of acetylation through targeting histone d...
Үндсэн зохиолч: | Khan, OA |
---|---|
Бусад зохиолчид: | La Thangue, NB |
Формат: | Дипломын ажил |
Хэл сонгох: | English |
Хэвлэсэн: |
2013
|
Нөхцлүүд: |
Ижил төстэй зүйлс
-
Mitochondrial modulators of hypoxia-related pathways in tumours
-н: Snell, CE
Хэвлэсэн: (2013) -
Role of HR23B, HDAC6 and Myd88 and their interplay in response to HDAC inhibitor treatment
-н: New, M
Хэвлэсэн: (2014) -
Angiogenesis in human lung tumours
-н: Ferguson, ML
Хэвлэсэн: (2008) -
Risk factors for haemorrhage in patients with haematological malignancies
-н: Estcourt, LJ
Хэвлэсэн: (2014) -
Regulation of stemness and differentiation in colorectal cancer
-н: Gandhi, S
Хэвлэсэн: (2010)